3-amino-6-[4-[2-(4-fluorophenyl)ethyl]quinolin-6-yl]-5-(5-methylfuran-2-yl)pyrazine-2-carbonitrile
C27H20FN5O — CID 158004215
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-amino-6-[4-[2-(4-fluorophenyl)ethyl]quinolin-6-yl]-5-(5-methylfuran-2-yl)pyrazine-2-carbonitrile
3-amino-6-[4-[2-(4-fluorophenyl)ethyl]quinolin-6-yl]-5-(5-methylfuran-2-yl)pyrazine-2-carbonitrile (PubChem CID 158004215) has the molecular formula C27H20FN5O and a molecular weight of 449.49 g/mol. Its IUPAC name is 3-amino-6-[4-[2-(4-fluorophenyl)ethyl]quinolin-6-yl]-5-(5-methylfuran-2-yl)pyrazine-2-carbonitrile.
Molecular Properties
| Compound Name | 3-amino-6-[4-[2-(4-fluorophenyl)ethyl]quinolin-6-yl]-5-(5-methylfuran-2-yl)pyrazine-2-carbonitrile |
|---|---|
| PubChem CID | 158004215 |
| Molecular Formula | C27H20FN5O |
| Molecular Weight | 449.49 g/mol |
| Exact Mass | 449.17 |
| IUPAC Name | 3-amino-6-[4-[2-(4-fluorophenyl)ethyl]quinolin-6-yl]-5-(5-methylfuran-2-yl)pyrazine-2-carbonitrile |
| SMILES | Cc1ccc(-c2nc(N)c(C#N)nc2-c2ccc3nccc(CCc4ccc(F)cc4)c3c2)o1 |
| InChI | InChI=1S/C27H20FN5O/c1-16-2-11-24(34-16)26-25(32-23(15-29)27(30)33-26)19-7-10-22-21(14-19)18(12-13-31-22)6-3-17-4-8-20(28)9-5-17/h2,4-5,7-14H,3,6H2,1H3,(H2,30,33) |
| InChIKey | FECAVJCQDLQIAK-UHFFFAOYSA-N |
| XLogP | 5.64 |
| TPSA | 101.62 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.49 |
| LogP ≤ 5 | 5.64 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158004215 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.